326. Deputy Bobby Aylward asked the Minister for Health further to Parliamentary Question No. 121 of 27 February 2019, if the required funding to hospitals will be made available for the provision of Fasenra to patients in a hospital setting further to the decision of the HSE leadership team in January 2019 to approve the drug for reimbursement; when he expects this funding decision to be made and communicated to patients; and if he will make a statement on the matter. [17433/19]

Summary

326. Deputy Bobby Aylward asked the Minister for Health further to Parliamentary Question No. 121 of 27 February 2019, if the required funding to hospitals will be made available for the provision of Fasenra to patients in a hospital setting further to the decision of the HSE leadership team in January 2019 to approve the drug for reimbursement; when he expects this funding decision to be made and communicated to patients; and if he will make a statement on the matter. [17433/19]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Medicinal Products Reimbursement

  xml · EN · 16 April 2019

  ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.